Circulating hs-CRP as Disease-Modifying Target via Microglial IL-1β Amplification
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
Unspecified Mechanismimmunomics
Convergent signals
No same-target convergence detected in this selection.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
7/11
dimensions won
Anti-CD47/SIRPα Checkpoint Therapy to En
9/11
dimensions won
Circulating hs-CRP as Disease-Modifying
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.55
0.55
Evidence
0.50
0.50
Novelty
0.60
0.60
Feasibility
0.45
0.45
Impact
0.45
0.40
Druggability
0.60
0.40
Safety
0.25
0.60
Competition
0.65
0.70
Data
0.45
0.65
Reproducible
0.50
0.55
KG Connect
0.50
0.50
Score Breakdown
Dimension
Anti-CD47/SIRPα Checkpoint The
Circulating hs-CRP as Disease-
Mechanistic
0.550
0.550
Evidence
0.500
0.500
Novelty
0.600
0.600
Feasibility
0.450
0.450
Impact
0.450
0.400
Druggability
0.600
0.400
Safety
0.250
0.600
Competition
0.650
0.700
Data
0.450
0.650
Reproducible
0.500
0.550
KG Connect
0.500
0.500
Evidence
Anti-CD47/SIRPα Checkpoint Therapy to Enhance Phagocytic Cle
No evidence citations yet
Circulating hs-CRP as Disease-Modifying Target via Microglia
No evidence citations yet
Debate Excerpts
Anti-CD47/SIRPα Checkpoint Therapy to Enhance Phag
4 rounds · quality: 0.50
Theorist
# Novel Therapeutic Hypotheses: Systemic Immune Profiling in Neurodegeneration
---
## Hypothesis 1: Circulating hs-CRP as a Disease-Modifying Target via Microglial IL-1β Amplification
**Descripti...
Skeptic
# Critical Evaluation of Systemic Immune Profiling Hypotheses in Neurodegeneration
I will systematically evaluate each hypothesis, identifying specific weaknesses, counter-evidence with PubMed cita...
Domain Expert
# Expert Evaluation: Systemic Immune Profiling in Neurodegeneration
## Executive Summary
The seven hypotheses present a coherent framework linking peripheral immune dysregulation to CNS neurodegen...
Synthesizer
```json
{
"ranked_hypotheses": [
{
"rank": 1,
"id": "Hypothesis_1",
"title": "Circulating hs-CRP as Disease-Modifying Target via Microglial IL-1β Amplification",
"targe...
Circulating hs-CRP as Disease-Modifying Target via
4 rounds · quality: 0.50
Theorist
# Novel Therapeutic Hypotheses: Systemic Immune Profiling in Neurodegeneration
---
## Hypothesis 1: Circulating hs-CRP as a Disease-Modifying Target via Microglial IL-1β Amplification
**Descripti...
Skeptic
# Critical Evaluation of Systemic Immune Profiling Hypotheses in Neurodegeneration
I will systematically evaluate each hypothesis, identifying specific weaknesses, counter-evidence with PubMed cita...
Domain Expert
# Expert Evaluation: Systemic Immune Profiling in Neurodegeneration
## Executive Summary
The seven hypotheses present a coherent framework linking peripheral immune dysregulation to CNS neurodegen...
Synthesizer
```json
{
"ranked_hypotheses": [
{
"rank": 1,
"id": "Hypothesis_1",
"title": "Circulating hs-CRP as Disease-Modifying Target via Microglial IL-1β Amplification",
"targe...